Literature DB >> 3515797

Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports.

M A Strassburg, S Greenland, F J Sorvillo, L E Lieb, L A Habel.   

Abstract

An outbreak of influenza A in nursing home residents is reported and other studies of influenza vaccine effectiveness in elderly populations are reviewed. The outbreak occurred in a Los Angeles nursing home between February and March 1983. Of the 87 residents, 46 (53%) were affected with influenza-like illness. Attack rates were similar between immunized and unimmunized residents (52% versus 58%), and yielded a vaccine effectiveness estimate of 10%. No additional protection could be demonstrated in residents who received vaccine for two consecutive years. Seven persons died (mortality rate of 8.1%); the mortality rate was greater in the unimmunized (15.8%) than in the immunized (6.2%). Because this study and other field studies of influenza vaccine are limited in precision and power, a statistical summary of the various studies was constructed. Summarizing the studies of institutionalized elderly (in hospitals and nursing and retirement homes) yielded an estimate of 74% for the average vaccine effectiveness in mortality reduction, and an estimate of 33% for the average effectiveness in preventing clinical illness. For the non-institutionalized elderly, the corresponding estimates were 47% for mortality, and 5% for clinical illness. Despite the obvious limitations of such summaries, it seems reasonable to conclude that influenza vaccines have on the average been of clear benefit in the institutionalized elderly, while the benefits in the non-institutionalized elderly have been less dramatic and may warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3515797     DOI: 10.1016/s0264-410x(86)80002-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

1.  Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population.

Authors:  T Menegon; V Baldo; C Bonello; D Dalla Costa; A Di Tommaso; R Trivello
Journal:  Eur J Epidemiol       Date:  1999-07       Impact factor: 8.082

2.  Measuring the impact of influenza on the hospital admission rates of the elderly in Ontario: a five-year admission rate analysis, 1988-1993.

Authors:  R E Upshur; V Goel
Journal:  Can J Public Health       Date:  2000 Mar-Apr

3.  Immune response to influenza vaccination in an elderly population.

Authors:  Lidia B Brydak; Magdalena Machała; Jolanta Myśliwska; Andrzej Myśliwski; Piotr Trzonkowski
Journal:  J Clin Immunol       Date:  2003-05       Impact factor: 8.317

4.  In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.

Authors:  D C Powers; L F Fries; B R Murphy; B Thumar; M L Clements
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

Review 5.  Impact of aging on gastrointestinal mucosal immunity.

Authors:  D L Schmucker; M F Heyworth; R L Owen; C K Daniels
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

6.  Efficacy of the influenza vaccine in patients with malignant lymphoma.

Authors:  Joseph J Mazza; Steven H Yale; Jodi R Arrowood; Cory E Reynolds; Ingrid Glurich; Po-Huang Chyou; James G Linneman; Kurt D Reed
Journal:  Clin Med Res       Date:  2005-11

Review 7.  The value of influenza and pneumococcal vaccines in the elderly.

Authors:  A S Monto; M S Terpenning
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

Review 8.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 9.  Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly?

Authors:  Paul V Targonski; Gregory A Poland
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.